Market Overview:
The global avian flu treatment market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of avian flu, rising demand for better and advanced treatment options, and growing awareness about avian flu treatments. The global avian flu treatment market is segmented on the basis of type into antibiotics, vaccines, antiviral agents, and immunoglobulins. The antibiotics segment is expected to account for the largest share of the global avian flu treatment market in 2018. This segment is projected to grow at a CAGR of 7.8% during the forecast period from 2018 to 2030 due to increasing demand for effective antibiotics against various strains of bird flu viruses. On the basis of application, hospitals are expected to account for the largest share of the global avian flu treatment market in 2018 followed by clinics and institutional health centers.
Product Definition:
Avian flu treatment is the use of medication or other methods to treat avian flu. The importance of avian flu treatment is that it can help prevent the spread of the disease and help those who are infected recover.
Antibiotics:
Antibiotics Market Size, Share & Trends Analysis Report By Type (Penicillin, Macrolides), By Application (Respiratory Tract Infections, Skin Infections), And Segment Forecasts, 2019 - 2025 -> The global antibiotics market size was valued at USD 20.9 billion in 2018 and is expected to grow at a compound annual growth rate (CAGR) of 3.8% from 2019 to 2025.
Vaccines:
Vaccines are biological agents used to stimulate the body's immune system to act against a specific disease-causing agent. There are two types of vaccines: attenuated and inactivated. Attenuated vaccines contain active ingredients that help fight diseases like measles, mumps, and rubella (MMR). Inactivating or formalin-fixed vaccine is made up of dead or disabled viruses; these can’t reproduce inside the body once administered.
Application Insights:
Based on the application, the market is segmented into hospitals, clinics, institutional health centers and online pharmacies. The hospitals segment dominated the overall market in terms of revenue in 2017. Hospitals are considered to be one of the most prominent places for obtaining information related to Avian Influenza as well as its treatment. In addition, these institutions act as a central point for all concerning issues regarding this disease and provide consultation services to patients from across various departments such as diagnostics laboratories and emergency rooms.
The clinics segment is expected to grow at a lucrative rate during the forecast period owing to rising awareness about bird flu among veterinary practitioners along with increasing incidences of this disease across poultry industries worldwide. These factors have led veterinarians globally towards adopting new diagnostic procedures along with antiviral therapy that has resulted in increased demand for treatments at clinics over past few years since 2014 (H1N1).
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. The region is expected to maintain its position during the forecast period due to increasing awareness about avian flu and rising investments for development of new drugs. Asia Pacific is estimated to be fastest growing regional market over the forecast period owing to high prevalence of diseases, increase in healthcare spending, and rise in demand for treatment options other than Tamiflu.
The outbreak has also resulted into an increased focus on developing novel therapies that are both effective and economical for treating human infections with H7N9 virus as well as other highly contagious strains such as H5N1 virus which cause severe respiratory disease among people across various countries including India, China, Indonesia etc., globally (Saravanan et al., 2016). Thus it can be concluded that there is a significant need & demand for anti-flu drugs especially those effective against highly contagious Avian Flu A(H7N9) viruses across regions globally.
Growth Factors:
- Increasing incidence of avian flu and other respiratory infections: The global incidence of avian flu is increasing rapidly, owing to the spread of the H5N1 virus. According to the World Health Organization (WHO), more than 400 people have died from avian flu since 2003. In addition, there has been a significant increase in the number of cases of other respiratory infections in recent years, which is driving demand for avian flu treatments.
- Growing awareness about available treatment options: There is growing awareness among patients and healthcare professionals about the availability of effective treatments for avian flu and other respiratory infections. This is helping to drive demand for these treatments.
- Technological advances in drug development: The pharmaceutical industry is making significant advances in drug development technologies, which are helping to accelerate the discovery and development of new therapies for respiratory infections, including those caused by avian flu viruses. This is contributing to growth in the market for avian flu treatments.
Scope Of The Report
Report Attributes
Report Details
Report Title
Avian Flu Treatment Market Research Report
By Type
Antibiotics, Vaccines, Antiviral Agents, Immunoglobulins
By Application
Hospitals, Clinics, Institutional Health Centers, Online Pharmacies
By Companies
Abbott, BioCryst Pharmaceuticals, Cipla, Forrest Pharmaceuticals, Gilead Sciences, GlaxoSmithKline, Macleods Pharmaceuticals, Pfizer, Roche, Sanofi, Sinovac Biotech.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
120
Number of Tables & Figures
84
Customization Available
Yes, the report can be customized as per your need.
Global Avian Flu Treatment Market Report Segments:
The global Avian Flu Treatment market is segmented on the basis of:
Types
Antibiotics, Vaccines, Antiviral Agents, Immunoglobulins
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Institutional Health Centers, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- BioCryst Pharmaceuticals
- Cipla
- Forrest Pharmaceuticals
- Gilead Sciences
- GlaxoSmithKline
- Macleods Pharmaceuticals
- Pfizer
- Roche
- Sanofi
- Sinovac Biotech.
Highlights of The Avian Flu Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics
- Vaccines
- Antiviral Agents
- Immunoglobulins
- By Application:
- Hospitals
- Clinics
- Institutional Health Centers
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Avian Flu Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Avian flu treatment is a vaccine that helps protect people from the H5N1 bird flu. It is given as an injection into the arm.
Some of the major players in the avian flu treatment market are Abbott, BioCryst Pharmaceuticals, Cipla, Forrest Pharmaceuticals, Gilead Sciences, GlaxoSmithKline, Macleods Pharmaceuticals, Pfizer, Roche, Sanofi, Sinovac Biotech..
The avian flu treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Avian Flu Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Avian Flu Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Avian Flu Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Avian Flu Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Avian Flu Treatment Market Size & Forecast, 2018-2028
4.5.1 Avian Flu Treatment Market Size and Y-o-Y Growth
4.5.2 Avian Flu Treatment Market Absolute $ Opportunity
Chapter 5 Global Avian Flu Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Avian Flu Treatment Market Size Forecast by Type
5.2.1 Antibiotics
5.2.2 Vaccines
5.2.3 Antiviral Agents
5.2.4 Immunoglobulins
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Avian Flu Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Avian Flu Treatment Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Institutional Health Centers
6.2.4 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Avian Flu Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Avian Flu Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Avian Flu Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Avian Flu Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Avian Flu Treatment Market Size Forecast by Type
9.6.1 Antibiotics
9.6.2 Vaccines
9.6.3 Antiviral Agents
9.6.4 Immunoglobulins
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Avian Flu Treatment Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Institutional Health Centers
9.10.4 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Avian Flu Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Avian Flu Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Avian Flu Treatment Market Size Forecast by Type
10.6.1 Antibiotics
10.6.2 Vaccines
10.6.3 Antiviral Agents
10.6.4 Immunoglobulins
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Avian Flu Treatment Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Institutional Health Centers
10.10.4 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Avian Flu Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Avian Flu Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Avian Flu Treatment Market Size Forecast by Type
11.6.1 Antibiotics
11.6.2 Vaccines
11.6.3 Antiviral Agents
11.6.4 Immunoglobulins
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Avian Flu Treatment Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Institutional Health Centers
11.10.4 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Avian Flu Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Avian Flu Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Avian Flu Treatment Market Size Forecast by Type
12.6.1 Antibiotics
12.6.2 Vaccines
12.6.3 Antiviral Agents
12.6.4 Immunoglobulins
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Avian Flu Treatment Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Institutional Health Centers
12.10.4 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Avian Flu Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Avian Flu Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Avian Flu Treatment Market Size Forecast by Type
13.6.1 Antibiotics
13.6.2 Vaccines
13.6.3 Antiviral Agents
13.6.4 Immunoglobulins
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Avian Flu Treatment Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Institutional Health Centers
13.10.4 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Avian Flu Treatment Market: Competitive Dashboard
14.2 Global Avian Flu Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 BioCryst Pharmaceuticals
14.3.3 Cipla
14.3.4 Forrest Pharmaceuticals
14.3.5 Gilead Sciences
14.3.6 GlaxoSmithKline
14.3.7 Macleods Pharmaceuticals
14.3.8 Pfizer
14.3.9 Roche
14.3.10 Sanofi
14.3.11 Sinovac Biotech.
